Author

Maria Myrthe Elisabeth Jongsma

SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB
SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB

Maria Myrthe Elisabeth Jongsma  et al.

EXCLUSIVE ENTERAL NUTRITION OR PREDNISOLONE INDUCTION TREATMENT: CLINICAL AND ENDOSCOPIC EVALUATION OF NEW-ONSET LUMINAL PAEDIATRIC CROHN'S DISEASE
EXCLUSIVE ENTERAL NUTRITION OR PREDNISOLONE INDUCTION TREATMENT: CLINICAL AND ENDOSCOPIC EVALUATION OF NEW-ONSET LUMINAL PAEDIATRIC CROHN'S DISEASE

Maria Myrthe Elisabeth Jongsma  et al.

CIRCULATING INFLAMMATORY PROTEIN AND CELLULAR PROFILES AT TIME OF DIAGNOSIS CLASSIFY INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO THEIR UNDERLYING IMMUNE RESPONSE AND CLINICAL DISEASE COURSE
CIRCULATING INFLAMMATORY PROTEIN AND CELLULAR PROFILES AT TIME OF DIAGNOSIS CLASSIFY INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO THEIR UNDERLYING IMMUNE RESPONSE AND CLINICAL DISEASE COURSE

Maria Myrthe Elisabeth Jongsma  et al.

CIRCULATING INFLAMMATORY PROTEIN AND CELLULAR PROFILES AT TIME OF DIAGNOSIS CLASSIFY INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO THEIR UNDERLYING IMMUNE RESPONSE AND CLINICAL DISEASE COURSE
CIRCULATING INFLAMMATORY PROTEIN AND CELLULAR PROFILES AT TIME OF DIAGNOSIS CLASSIFY INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO THEIR UNDERLYING IMMUNE RESPONSE AND CLINICAL DISEASE COURSE

Maria Myrthe Elisabeth Jongsma  et al.

Item 1 - 4 / 4
1